Haemonetics Corporation
22
3
3
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.5%
1 terminated/withdrawn out of 22 trials
94.1%
+7.6% vs industry average
14%
3 trials in Phase 3/4
38%
6 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve Replacement Evaluation
Role: collaborator
VASC-AF Study: Vascular Closure vs Manual Compression
Role: collaborator
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Role: collaborator
An Observational Trial to Assess the Performance of the TEG® 6s Diagnostic System With the Citrated K, KH, RTH, FFH Cartridge
Role: lead
Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers
Role: lead
Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder
Role: lead
Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution
Role: lead
IMPACT (Improving Plasma Collection) Clinical Trial
Role: lead
The Evaluation of Hemostasis in Hospitalized COVID-19 Patients
Role: collaborator
Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
Role: lead
Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma
Role: collaborator
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
Role: collaborator
Procedure For The Reference Range Study For Absolute MA
Role: lead
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
Role: collaborator
Clinical Evaluation of the OrthoPAT Advance System
Role: lead
Clinical Investigational Protocol for 2 RBC Single Unit Recovery on MCS®+ 8150 Using LN832 Disposable Sets (US)
Role: lead
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Role: collaborator
RapidTEG MA Validation
Role: lead
A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients
Role: collaborator
Thromboelastography (TEG) Reference Range Study
Role: lead